MD Anderson writes off $62M IBM Watson for Oncology deployment after five years
According to CIO.com, MD Anderson Cancer Center abandoned its 2012 partnership with IBM Watson after spending approximately $62 million over five years, revealing that healthcare AI's primary bottleneck is integration with existing clinical infrastructure rather than model intelligence.
Topics
Sources
- PressRead article
Go deeper
This intelligence is sourced automatically from public sources across the web and synthesised by the Prefactor AI pipeline. Stories are reviewed before publication.